SOQUIMICH B ADR 2026 Q2
Earnings Overview & AI Insights

Earnings Performance

Summary of Financial Performance: SQM reported a strong second quarter 2026 across its main business lines. Lithium was a standout, with record quarterly sales volumes above 84,000 metric tons of lithium carbonate equivalent from Chile and Australia. Management said lithium prices improved in Q2 on stronger-than-expected demand. Iodine also posted good results on robust demand and favorable pricing, while specialty plant nutrition delivered another strong quarter on higher prices and volumes. The company highlighted more than $1.6 billion in payments to the Chilean government and related entities in the first half of the year.

Company Outlook & Strategy: Management remains constructive on the medium- and long-term outlook, especially for lithium and the energy transition. SQM expects global lithium demand to exceed 2.1 million metric tons in 2026. In Chile, Novandino Litio is expected to produce 280,000–290,000 metric tons LCE this year, with capacity rising to about 300,000 metric tons next year. The company also advanced the Salar Futuro project with Codelco, involving roughly $3 billion of investment over seven years, aimed at increasing production and lowering environmental impact. SQM updated its capex outlook to about $3 billion for 2026–2028, focused on growth and cost competitiveness.

Key Industry Trends: Lithium market conditions improved in Q2, supported by stronger demand, though management noted prices remain volatile and difficult to predict. In iodine, demand remained robust, and plant nutrition benefited from supply constraints in certain markets that are expected to normalize toward year-end. The company continues to see favorable long-term fundamentals tied to the energy transition and industrial demand.

Operational Highlights: SQM reached record quarterly lithium sales volumes and continued to expand production capabilities in Chile and Australia. In Australia, the Mount Holland expansion with Wesfarmers will double spodumene concentrate capacity to about 350,000 metric tons per year on an SQM-shares basis, with first production expected in 2030. In iodine, a seawater pipeline is in commissioning and should add flexibility to production. SQM is now producing iodine from four operations and expects 2026 iodine output of about 15,500 metric tons. Specialty plant nutrition volumes are still expected to rise about 10% in 2026.

Challenges & Risks: Management highlighted volatility in lithium prices and uncertainty around index-linked realizations. The gap between Chilean lithium pricing and international spodumene pricing was discussed as a function of conversion costs, yields, and shipment timing. For plant nutrition, supply constraints that supported pricing are expected to gradually normalize, which could pressure pricing later in the year. Future projects, including Salar Futuro, remain subject to regulatory approvals.

Key Analyst Questions & Responses: Analyst Joel Jackson asked about Q3 lithium pricing, volumes, and margins; management said Q3 volumes should remain strong and prices should be broadly in line with the first half, with Q3 margins expected to be similar to Q2, though costs should remain below last year due to efficiency gains and scale. He also asked about the widening price gap between Novandino and international lithium; management explained that comparisons must adjust for conversion costs, conversion yields, and the timing of discrete shipments, which are sold based on market conditions at shipment.